Abstract
Here we describe an assay for simultaneous measurement of cellular uptake rates of long-chain fatty acids (LCFA) and glucose that can be applied to cells in suspension. The uptake assay includes the use of radiolabeled substrates at such concentrations and incubation periods that exact information is provided about unidirectional uptakes rates. Cellular uptake of both substrates is under regulation of AMPK. The underlying mechanism includes the translocation of LCFA and glucose transporters from intracellular membrane compartments to the cell surface, leading to an increase in substrate uptake. In this chapter, we explain the principles of the uptake assay before detailing the exact procedure. We also provide information of the specific LCFA and glucose transporters subject to AMPK-mediated subcellular translocation. Finally, we discuss the application of AMPK inhibitors and activators in combination with cellular substrate uptake assays.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106(2):171–176. https://doi.org/10.1172/JCI10583
Luiken JJ, Schaap FG, van Nieuwenhoven FA, van der Vusse GJ, Bonen A, Glatz JF (1999) Cellular fatty acid transport in heart and skeletal muscle as facilitated by proteins. Lipids 34(Suppl):S169–S175
Glatz JF, Luiken JJ, Bonen A (2010) Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev 90(1):367–417. https://doi.org/10.1152/physrev.00003.2009
Mueckler M (1994) Facilitative glucose transporters. Eur J Biochem 219(3):713–725
Rose H, Hennecke T, Kammermeier H (1990) Sarcolemmal fatty acid transfer in isolated cardiomyocytes governed by albumin/membrane-lipid partition. J Mol Cell Cardiol 22(8):883–892
Hamilton JA, Johnson RA, Corkey B, Kamp F (2001) Fatty acid transport: the diffusion mechanism in model and biological membranes. J Mol Neurosci 16(2–3):99–108.; discussion 151–157. https://doi.org/10.1385/JMN:16:2-3:99
Sorrentino D, Stump D, Potter BJ, Robinson RB, White R, Kiang CL, Berk PD (1988) Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. J Clin Invest 82(3):928–935. https://doi.org/10.1172/JCI113700
Luiken JJ, van Nieuwenhoven FA, America G, van der Vusse GJ, Glatz JF (1997) Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: involvement of sarcolemmal proteins. J Lipid Res 38(4):745–758
Schwenk RW, Dirkx E, Coumans WA, Bonen A, Klip A, Glatz JF, Luiken JJ (2010) Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia 53(10):2209–2219. https://doi.org/10.1007/s00125-010-1832-7
Van Nieuwenhoven FA, Luiken JJ, De Jong YF, Grimaldi PA, Van der Vusse GJ, Glatz JF (1998) Stable transfection of fatty acid translocase (CD36) in a rat heart muscle cell line (H9c2). J Lipid Res 39(10):2039–2047
Oakes ND, Kjellstedt A, Forsberg GB, Clementz T, Camejo G, Furler SM, Kraegen EW, Olwegard-Halvarsson M, Jenkins AB, Ljung B (1999) Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer. J Lipid Res 40(6):1155–1169
Verberne HJ, Sloof GW, Beets AL, Murphy AM, van Eck-Smit BL, Knapp FF (2003) 125I-BMIPP and 18F-FDG uptake in a transgenic mouse model of stunned myocardium. Eur J Nucl Med Mol Imaging 30(3):431–439
Vorum H, Brodersen R, Kragh-Hansen U, Pedersen AO (1992) Solubility of long-chain fatty acids in phosphate buffer at pH 7.4. Biochim Biophys Acta 1126(2):135–142
Richieri GV, Ogata RT, Kleinfeld AM (1994) Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J Biol Chem 269(39):23918–23930
Andersen BL, Tarpley HT, Regen DM (1978) Characterization of beta-hydroxybutyrate transport in rat erythrocytes and thymocytes. Biochim Biophys Acta 508(3):525–538
Luiken JJ, Coort SL, Willems J, Coumans WA, Bonen A, van der Vusse GJ, Glatz JF (2003) Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52(7):1627–1634
Klip A, Schertzer JD, Bilan PJ, Thong F, Antonescu C (2009) Regulation of glucose transporter 4 traffic by energy deprivation from mitochondrial compromise. Acta Physiol (Oxf) 196(1):27–35. https://doi.org/10.1111/j.1748-1716.2009.01974.x
Abbud W, Habinowski S, Zhang JZ, Kendrew J, Elkairi FS, Kemp BE, Witters LA, Ismail-Beigi F (2000) Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport. Arch Biochem Biophys 380(2):347–352. https://doi.org/10.1006/abbi.2000.1935
Abel ED (2004) Glucose transport in the heart. Front Biosci 9:201–215
Richter EA, Hargreaves M (2013) Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 93(3):993–1017. https://doi.org/10.1152/physrev.00038.2012
Jain SS, Chabowski A, Snook LA, Schwenk RW, Glatz JF, Luiken JJ, Bonen A (2009) Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Lett 583(13):2294–2300. https://doi.org/10.1016/j.febslet.2009.06.020
Habets DD (2008) Thesis: “Regulation of cardiac long-chain fatty acid and glucose utilization. Studies with cardiomyocytes from genetically manipulated mice” Thesis Chapter 5: AICAR stimulates long-chain fatty acid uptake and oxidation in mouse heart independent of CD36
Thong FS, Bilan PJ, Klip A (2007) The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes 56(2):414–423. https://doi.org/10.2337/db06-0900
Abbott MJ, Edelman AM, Turcotte LP (2009) CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle. Am J Physiol Regul Integr Comp Physiol 297(6):R1724–R1732. https://doi.org/10.1152/ajpregu.00179.2009
Habets DD, Coumans WA, El Hasnaoui M, Zarrinpashneh E, Bertrand L, Viollet B, Kiens B, Jensen TE, Richter EA, Bonen A, Glatz JF, Luiken JJ (2009) Crucial role for LKB1 to AMPKalpha2 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes. Biochim Biophys Acta 1791(3):212–219. https://doi.org/10.1016/j.bbalip.2008.12.009
Samovski D, Su X, Xu Y, Abumrad NA, Stahl PD (2012) Insulin and AMPK regulate FA translocase/CD36 plasma membrane recruitment in cardiomyocytes via Rab GAP AS160 and Rab8a Rab GTPase. J Lipid Res 53(4):709–717. https://doi.org/10.1194/jlr.M023424
Luiken JJ, Glatz JF, Neumann D (2015) Cardiac contraction-induced GLUT4 translocation requires dual signaling input. Trends Endocrinol Metab 26(8):404–410. https://doi.org/10.1016/j.tem.2015.06.002
Luiken JJ, Coort SL, Koonen DP, van der Horst DJ, Bonen A, Zorzano A, Glatz JF (2004) Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters. Pflugers Arch 448(1):1–15. https://doi.org/10.1007/s00424-003-1199-4
Yamaguchi S, Katahira H, Ozawa S, Nakamichi Y, Tanaka T, Shimoyama T, Takahashi K, Yoshimoto K, Imaizumi MO, Nagamatsu S, Ishida H (2005) Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 289(4):E643–E649. https://doi.org/10.1152/ajpendo.00456.2004
Weisiger RA, Fitz JG, Scharschmidt BF (1989) Hepatic oleate uptake. Electrochemical driving forces in intact rat liver. J Clin Invest 83(2):411–420. https://doi.org/10.1172/JCI113899
Park KS, Jo I, Pak K, Bae SW, Rhim H, Suh SH, Park J, Zhu H, So I, Kim KW (2002) FCCP depolarizes plasma membrane potential by activating proton and Na+ currents in bovine aortic endothelial cells. Pflugers Arch 443(3):344–352. https://doi.org/10.1007/s004240100703
Liu X, Chhipa RR, Pooya S, Wortman M, Yachyshin S, Chow LM, Kumar A, Zhou X, Sun Y, Quinn B, McPherson C, Warnick RE, Kendler A, Giri S, Poels J, Norga K, Viollet B, Grabowski GA, Dasgupta B (2014) Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. Proc Natl Acad Sci U S A 111(4):E435–E444. https://doi.org/10.1073/pnas.1311121111
Bonen A, Han XX, Habets DD, Febbraio M, Glatz JF, Luiken JJ (2007) A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am J Physiol Endocrinol Metab 292(6):E1740–E1749. https://doi.org/10.1152/ajpendo.00579.2006
Russell RR 3rd, Bergeron R, Shulman GI, Young LH (1999) Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Phys 277(2 Pt 2):H643–H649
Angin Y, Schwenk RW, Nergiz-Unal R, Hoebers N, Heemskerk JW, Kuijpers MJ, Coumans WA, van Zandvoort MA, Bonen A, Neumann D, Glatz JF, Luiken JJ (2014) Calcium signaling recruits substrate transporters GLUT4 and CD36 to the sarcolemma without increasing cardiac substrate uptake. Am J Physiol Endocrinol Metab 307(2):E225–E236. https://doi.org/10.1152/ajpendo.00655.2013
Dirkx E, Schwenk RW, Coumans WA, Hoebers N, Angin Y, Viollet B, Bonen A, van Eys GJ, Glatz JF, Luiken JJ (2012) Protein kinase D1 is essential for contraction-induced glucose uptake but is not involved in fatty acid uptake into cardiomyocytes. J Biol Chem 287(8):5871–5881. https://doi.org/10.1074/jbc.M111.281881
Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108(8):1167–1174. https://doi.org/10.1172/JCI13505
Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A, Goodyear LJ (2002) Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51(7):2074–2081
Yang J, Holman GD (2006) Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis. Endocrinology 147(6):2728–2736. https://doi.org/10.1210/en.2005-1433
Cool B, Zinker B, Chiou W, Kifle L, Cao N, Perham M, Dickinson R, Adler A, Gagne G, Iyengar R, Zhao G, Marsh K, Kym P, Jung P, Camp HS, Frevert E (2006) Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 3(6):403–416. https://doi.org/10.1016/j.cmet.2006.05.005
Lai YC, Kviklyte S, Vertommen D, Lantier L, Foretz M, Viollet B, Hallen S, Rider MH (2014) A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators. Biochem J 460(3):363–375. https://doi.org/10.1042/BJ20131673
Rajamohan F, Reyes AR, Frisbie RK, Hoth LR, Sahasrabudhe P, Magyar R, Landro JA, Withka JM, Caspers NL, Calabrese MF, Ward J, Kurumbail RG (2016) Probing the enzyme kinetics, allosteric modulation and activation of alpha1- and alpha2-subunit-containing AMP-activated protein kinase (AMPK) heterotrimeric complexes by pharmacological and physiological activators. Biochem J 473(5):581–592. https://doi.org/10.1042/BJ20151051
Xiao B, Sanders MJ, Carmena D, Bright NJ, Haire LF, Underwood E, Patel BR, Heath RB, Walker PA, Hallen S, Giordanetto F, Martin SR, Carling D, Gamblin SJ (2013) Structural basis of AMPK regulation by small molecule activators. Nat Commun 4:3017. https://doi.org/10.1038/ncomms4017
Momken I, Chabowski A, Dirkx E, Nabben M, Jain SS, McFarlan JT, Glatz JF, Luiken JJ, Bonen A (2017) A new leptin-mediated mechanism for stimulating fatty acid oxidation: a pivotal role for sarcolemmal FAT/CD36. Biochem J 474(1):149–162. https://doi.org/10.1042/BCJ20160804
Palanivel R, Eguchi M, Shuralyova I, Coe I, Sweeney G (2006) Distinct effects of short- and long-term leptin treatment on glucose and fatty acid uptake and metabolism in HL-1 cardiomyocytes. Metabolism 55(8):1067–1075. https://doi.org/10.1016/j.metabol.2006.03.020
Berti L, Gammeltoft S (1999) Leptin stimulates glucose uptake in C2C12 muscle cells by activation of ERK2. Mol Cell Endocrinol 157(1–2):121–130
Mu J, Brozinick JT Jr, Valladares O, Bucan M, Birnbaum MJ (2001) A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7(5):1085–1094
Samari HR, Seglen PO (1998) Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase. J Biol Chem 273(37):23758–23763
Musi N, Hayashi T, Fujii N, Hirshman MF, Witters LA, Goodyear LJ (2001) AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab 280(5):E677–E684
Henin N, Vincent MF, Van den Berghe G (1996) Stimulation of rat liver AMP-activated protein kinase by AMP analogues. Biochim Biophys Acta 1290(2):197–203
Iwatsubo K, Bravo C, Uechi M, Baljinnyam E, Nakamura T, Umemura M, Lai L, Gao S, Yan L, Zhao X, Park M, Qiu H, Okumura S, Iwatsubo M, Vatner DE, Vatner SF, Ishikawa Y (2012) Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase. Am J Physiol Heart Circ Physiol 302(12):H2622–H2628. https://doi.org/10.1152/ajpheart.00190.2012
Niu W, Bilan PJ, Ishikura S, Schertzer JD, Contreras-Ferrat A, Fu Z, Liu J, Boguslavsky S, Foley KP, Liu Z, Li J, Chu G, Panakkezhum T, Lopaschuk GD, Lavandero S, Yao Z, Klip A (2010) Contraction-related stimuli regulate GLUT4 traffic in C2C12-GLUT4myc skeletal muscle cells. Am J Physiol Endocrinol Metab 298(5):E1058–E1071. https://doi.org/10.1152/ajpendo.00773.2009
Merlin J, Evans BA, Csikasz RI, Bengtsson T, Summers RJ, Hutchinson DS (2010) The M3-muscarinic acetylcholine receptor stimulates glucose uptake in L6 skeletal muscle cells by a CaMKK-AMPK-dependent mechanism. Cell Signal 22(7):1104–1113. https://doi.org/10.1016/j.cellsig.2010.03.004
Vogt J, Traynor R, Sapkota GP (2011) The specificities of small molecule inhibitors of the TGFss and BMP pathways. Cell Signal 23(11):1831–1842. https://doi.org/10.1016/j.cellsig.2011.06.019
Tokumitsu H, Inuzuka H, Ishikawa Y, Ikeda M, Saji I, Kobayashi R (2002) STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase. J Biol Chem 277(18):15813–15818. https://doi.org/10.1074/jbc.M201075200
Witczak CA, Sharoff CG, Goodyear LJ (2008) AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci 65(23):3737–3755. https://doi.org/10.1007/s00018-008-8244-6
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Luiken, J.J.F.P., Neumann, D., Glatz, J.F.C., Coumans, W.A., Chanda, D., Nabben, M. (2018). Assessment of AMPK-Stimulated Cellular Long-Chain Fatty Acid and Glucose Uptake. In: Neumann, D., Viollet, B. (eds) AMPK. Methods in Molecular Biology, vol 1732. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7598-3_22
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7598-3_22
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7597-6
Online ISBN: 978-1-4939-7598-3
eBook Packages: Springer Protocols